These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

246 related items for PubMed ID: 12738486

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Ileocolonic tuberculosis clinically, endoscopically, and radiologically mimicking Crohn's disease: disseminated infection after treatment with infliximab.
    Cappell MS, Saad A, Bortman JS, Amin M.
    J Crohns Colitis; 2014 Jun; 8(6):560-2. PubMed ID: 24360259
    [No Abstract] [Full Text] [Related]

  • 5.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 6. Pericarditis as a complication of infliximab therapy in Crohn's disease.
    Burke JP, Kelleher B, Ramadan S, Quinlan M, Sugrue D, O'Donovan MA.
    Inflamm Bowel Dis; 2008 Mar; 14(3):428-9. PubMed ID: 17924565
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Complications of infliximab therapy in children and adolescents affected by Crohn's disease.
    Diamanti A, Papadatou B, Knafelz D, Gambarara M, Ferretti F, Castro M.
    Am J Gastroenterol; 2003 Dec; 98(12):2812-3. PubMed ID: 14687847
    [No Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Infliximab as first-line therapy for Crohn's disease is premature.
    Greenberg GR.
    Inflamm Bowel Dis; 2002 Jan; 8(1):60-2; discussion 63-5. PubMed ID: 11837941
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13. [Indications and results of infliximab in Crohn's disease].
    Karoui S, Boubaker J, Filali A.
    Tunis Med; 2004 Dec; 82(12):1057-63. PubMed ID: 15822505
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Infliximab induced liver injury in Crohn's disease: a challenging diagnosis.
    Carvalheiro J, Mendes S, Sofia C.
    J Crohns Colitis; 2014 May; 8(5):436-7. PubMed ID: 24291019
    [No Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Prolonged duration of response to infliximab in early pediatric Crohn's disease.
    Kugathasan S.
    J Pediatr Gastroenterol Nutr; 2001 Sep; 33 Suppl 1():S40-3. PubMed ID: 11685975
    [No Abstract] [Full Text] [Related]

  • 20. [Pneumocystis pneumonia during infliximab treatment for active Crohn's colitis].
    Minnee RC, Stokkers P, Riemens SC, Hommes DW.
    Ned Tijdschr Geneeskd; 2005 Oct 08; 149(41):2290-5. PubMed ID: 16240855
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 13.